Clinical TrialsSearch results for "cytarabine"
Number of results: 40
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28
Completed
- A phase Ib, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-Hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed/refractory multiple myeloma
- non-Hodgkin lymphoma, acute myeloid leukemia, multiple myeloma
- Yonemura Masataka
- 2021-10-28